Article
U.S.
(2020)
Merck & Co Inc , which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.
FoundryBase
updated about 10 hours ago
Comments
Related Chunks
Related chunks with this resource
A collection of articles about Drug Research and the Pharma industry
a collection of articles about Merck Pharmaceutical company - and their treatment, vaccine development for COVID19 Coronavirus
RELATED RESOURCES
with chunks in common
2018
Cancer ‘vaccine’ eliminates tumors in mice | News Center | Stanford Medicine
Saved by: FoundryBase
used in 1 chunk
2018
The Quant King, the Drug Hunter, and the Quest to Unlock New Cures - Bloomberg
Saved by: FoundryBase
used in 1 chunk
2018
Can I borrow a molecule? Biosimilars 2018-09-04 || The Economist
Saved by: FoundryBase
used in 1 chunk
2018
After century of removing appendixes, docs find antibiotics can be enough | Ars Technica
Saved by: FoundryBase
used in 2 chunks
2019
DNA-testing company 23andMe has signed a $300 million deal with a drug giant
Saved by: FoundryBase
used in 2 chunks
2019
Millions of women are missing out on hormone replacement therapy - Managing menopause - The Economist
Saved by: FoundryBase
used in 1 chunk
2020
The $1 billion bet: Pharma giant and U.S. government team up in all-out coronavirus vaccine push
Saved by: FoundryBase
used in 2 chunks
2020
Pfizer, U.S. Reach $1.95 Billion Coronavirus Vaccine Deal
Saved by: FoundryBase
used in 2 chunks
2021
In a major setback, Merck to stop developing its two Covid-19 vaccines and focus on therapies
Saved by: FoundryBase
used in 2 chunks
2021
Merck's COVID-19 antiviral pill is now approved in the U.K. : Coronavirus Updates : NPR
Saved by: FoundryBase
used in 1 chunk
MORE RELATED CONTENT
with shared categories
2020
The story of mRNA: How a once-dismissed idea became a leading technology in the Covid vaccine race
Saved by: FoundryBase
used in 2 chunks
2021
FDA grants historic approval to Alzheimer’s drug designed to slow cognitive decline
Saved by: FoundryBase
used in 1 chunk
2021
What went wrong with America’s $44 million vaccine data system? | MIT Technology Review
Saved by: FoundryBase
used in 4 chunks
2021
Sanofi to help produce 100 million Pfizer/BioNTech vaccine doses | Reuters
Saved by: FoundryBase
used in 3 chunks
2021
In a major setback, Merck to stop developing its two Covid-19 vaccines and focus on therapies
Saved by: FoundryBase
used in 2 chunks
2021
Personalized Skin Cancer Vaccine Shows Promise in New Trial Results
Saved by: FoundryBase
used in 4 chunks
2020
Why Oxford’s positive COVID vaccine results are puzzling scientists
Saved by: FoundryBase
used in 1 chunk
2020
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store
Saved by: FoundryBase
used in 1 chunk
2020
Amazon launches Amazon Pharmacy, a delivery service for prescription medications
Saved by: FoundryBase
used in 2 chunks
2020
Dozens of COVID-19 vaccines are in development. Here are the ones to follow - National Geographic
Saved by: FoundryBase
used in 2 chunks
No comments yet. Be the first to comment!